Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Oct 8 · below the Ichimoku cloud · RSI 48 · MACD below its signal
| 4.00 | 52-week high | +827.00% |
| 0.9500 | Previous week high | +120.16% |
| 0.4842 | R3 (classic) | +12.21% |
| 0.4740 | Previous month high | +9.85% |
| 0.4710 | Previous week low | +9.15% |
| 0.4620 | R2 (classic) | +7.08% |
| 0.4468 | R1 (classic) | +3.54% |
| 0.4399 | Previous day high | +1.95% |
| 0.4315 | Price now | |
| 0.4246 | Pivot | −1.59% |
| 0.4094 | S1 (classic) | −5.13% |
| 0.4025 | Previous day low | −6.72% |
| 0.3872 | S2 (classic) | −10.26% |
| 0.3720 | S3 (classic) | −13.80% |
| 0.3550 | Previous month low | −17.73% |
| 0.3550 | 52-week low | −17.73% |
None of the 29 investors followed here reported a position in BEAT in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a BEAT trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -39.6 | 4.1 | -19.2 | -29.7 | 2.0 | -14.3 | -33.2 | -6.2 | -21.9 | 17.6 | −82.0% | ||
| 2025 | 4.3 | -15.8 | -0.5 | -12.9 | -2.9 | -26.5 | -9.6 | 19.5 | 22.2 | 12.1 | -58.4 | 211.7 | +4.3% |
| 2024 | -20.4 | -22.5 | 50.3 | -7.8 | 38.3 | -7.6 | 1.6 | -10.0 | -1.3 | 4.3 | 26.4 | -24.8 | −2.1% |
| 2023 | -20.7 | -10.3 | -34.6 | -0.4 | 4.0 | 2.6 | 26.1 | -31.3 | 2.9 | -42.3 | 16.9 | 62.1 | −51.8% |
| 2022 | -29.5 | -19.4 | 5.4 | -25.7 | 5.8 | -11.0 | 9.3 | -9.2 | 204.7 | -14.6 | 28.2 | 14.3 | +58.4% |
| 2021 | -13.7 | −13.7% |
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 23, 2026 | Vajdic BranislavPresident | Stock Award(Grant) at price 0.00 per share. | 3.06M | — |
| Jul 23, 2026 | Persen Kenneth HarryChief Technology Officer | Stock Award(Grant) at price 0.00 per share. | 105.7K | — |
| Jul 23, 2026 | Cruickshank TimothyChief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 167.8K | — |
| Apr 15, 2026 | Ferrari Richard MDirector | Purchase at price 0.80 per share. | 62.5K | $50.00K |
| Apr 15, 2026 | Ferrari Richard MDirector | Purchase at price 0.80 per share. | 57.5K | $46.00K |
| Apr 15, 2026 | Elfrink Willem P.Director | Purchase at price 0.80 per share. | 187.5K | $150.00K |
| Apr 15, 2026 | Vajdic BranislavDirector | Purchase at price 0.80 per share. | 31.3K | $25.00K |
| Apr 15, 2026 | Ortigas-Wedekind MargaritaDirector | Purchase at price 0.80 per share. | 25K | $20.00K |
| Apr 15, 2026 | Strome Mark E.Director | Purchase at price 0.80 per share. | 750K | $600.00K |
| Apr 15, 2026 | Eno Robert PaulPresident | Purchase at price 0.80 per share. | 12.5K | $10.00K |
| Apr 15, 2026 | Jaff Michael R.Director | Purchase at price 0.80 per share. | 31.3K | $25.00K |
| Apr 15, 2026 | Cruickshank TimothyChief Financial Officer | Purchase at price 0.80 per share. | 31.3K | $25.00K |
| Feb 8, 2026 | Ferrari Richard MDirector | Stock Award(Grant) at price 0.00 per share. | 50K | — |
| Feb 8, 2026 | Nelson Kenneth Warwick IiiDirector | Stock Award(Grant) at price 0.00 per share. | 17.2K | — |
| Feb 8, 2026 | Jaff Michael R.Director | Stock Award(Grant) at price 0.00 per share. | 20.7K | — |
| Dec 17, 2025 | De Urioste George A.Director | Sale at price 2.83 - 3.68 per share. | 57.1K | $182.09K |
| Dec 16, 2025 | Strome Mark E.Beneficial Owner of more than 10% of a Class of Security | Sale at price 3.58 per share. | 250K | $895.00K |
| Feb 13, 2025 | Ferrari Richard MDirector | Purchase at price 2.13 per share. | 29.4K | $62.65K |
| Feb 13, 2025 | Cruickshank TimothyChief Financial Officer | Purchase at price 2.13 per share. | 17.6K | $37.59K |
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms. HeartBeam, Inc. was incorporated in 2015 and is based in Santa Clara, California.
Buy / hold / sell counts